| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid binding | 1.55e-10 | 28 | 112 | 7 | GO:0001972 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 8.53e-10 | 35 | 112 | 7 | GO:0015020 | |
| GeneOntologyMolecularFunction | retinoid binding | 8.80e-09 | 48 | 112 | 7 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 1.02e-08 | 49 | 112 | 7 | GO:0019840 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 2.38e-06 | 107 | 112 | 7 | GO:0033293 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 2.40e-06 | 153 | 112 | 8 | GO:0008194 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 3.45e-05 | 66 | 112 | 5 | GO:0005080 | |
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 9.12e-05 | 16 | 112 | 3 | GO:0023029 | |
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 9.32e-05 | 3 | 112 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 1.56e-04 | 19 | 112 | 3 | GO:0032394 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 1.89e-04 | 211 | 112 | 7 | GO:0016758 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 2.21e-04 | 288 | 112 | 8 | GO:0016757 | |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 3.08e-04 | 5 | 112 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 4.02e-04 | 239 | 112 | 7 | GO:0031406 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | UGT1A10 UGT1A8 UGT1A7 UGT1A5 IRAK2 UGT1A9 UGT1A4 UGT1A3 TAF1L | 4.09e-04 | 398 | 112 | 9 | GO:0046982 |
| GeneOntologyMolecularFunction | organic acid binding | 5.78e-04 | 254 | 112 | 7 | GO:0043177 | |
| GeneOntologyMolecularFunction | fatty acid binding | 6.12e-04 | 69 | 112 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.86e-03 | 229 | 112 | 6 | GO:0140993 | |
| GeneOntologyMolecularFunction | MAP-kinase scaffold activity | 2.34e-03 | 13 | 112 | 2 | GO:0005078 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 2.34e-03 | 13 | 112 | 2 | GO:0008046 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.26e-11 | 21 | 112 | 7 | GO:0052695 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 3.72e-11 | 13 | 112 | 6 | GO:0009812 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 6.95e-11 | 26 | 112 | 7 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 6.95e-11 | 26 | 112 | 7 | GO:0006063 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 4.10e-09 | 5 | 112 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 4.10e-09 | 5 | 112 | 4 | GO:0052696 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 1.23e-08 | 6 | 112 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 1.23e-08 | 6 | 112 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 1.23e-08 | 6 | 112 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 1.69e-07 | 10 | 112 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 1.69e-07 | 10 | 112 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 3.94e-07 | 12 | 112 | 4 | GO:0052697 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 1.71e-06 | 67 | 112 | 6 | GO:0019748 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 4.59e-06 | 21 | 112 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 9.15e-06 | 52 | 112 | 5 | GO:0008210 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 1.24e-05 | 94 | 112 | 6 | GO:0042440 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 3.37e-05 | 34 | 112 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 6.48e-05 | 40 | 112 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 1.21e-04 | 141 | 112 | 6 | GO:0006805 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | MYO5A UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 ACAD10 UGT1A4 UGT1A3 FASN TRIM63 FADS2 ACOT2 | 1.69e-04 | 731 | 112 | 13 | GO:0032787 |
| GeneOntologyBiologicalProcess | melanosome transport | 2.23e-04 | 22 | 112 | 3 | GO:0032402 | |
| GeneOntologyBiologicalProcess | establishment of melanosome localization | 2.55e-04 | 23 | 112 | 3 | GO:0032401 | |
| GeneOntologyBiologicalProcess | pigment granule transport | 2.55e-04 | 23 | 112 | 3 | GO:0051904 | |
| GeneOntologyBiologicalProcess | establishment of pigment granule localization | 2.90e-04 | 24 | 112 | 3 | GO:0051905 | |
| GeneOntologyBiologicalProcess | melanosome localization | 3.29e-04 | 25 | 112 | 3 | GO:0032400 | |
| GeneOntologyBiologicalProcess | pigment granule localization | 3.70e-04 | 26 | 112 | 3 | GO:0051875 | |
| Domain | UDPGT | 2.35e-11 | 21 | 111 | 7 | PF00201 | |
| Domain | UDPGT | 2.35e-11 | 21 | 111 | 7 | PS00375 | |
| Domain | UDP_glucos_trans | 2.35e-11 | 21 | 111 | 7 | IPR002213 | |
| Domain | FATC | 3.46e-04 | 5 | 111 | 2 | PF02260 | |
| Domain | FERM_CS | 3.78e-04 | 24 | 111 | 3 | IPR019747 | |
| Domain | FAT | 5.17e-04 | 6 | 111 | 2 | PS51189 | |
| Domain | FATC | 5.17e-04 | 6 | 111 | 2 | PS51190 | |
| Domain | FAT | 5.17e-04 | 6 | 111 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 5.17e-04 | 6 | 111 | 2 | IPR003151 | |
| Domain | FATC_dom | 5.17e-04 | 6 | 111 | 2 | IPR003152 | |
| Domain | PIK_FAT | 5.17e-04 | 6 | 111 | 2 | IPR014009 | |
| Domain | FATC | 5.17e-04 | 6 | 111 | 2 | SM01343 | |
| Domain | RNA_pol_II-bd | 7.21e-04 | 7 | 111 | 2 | IPR006903 | |
| Domain | CTD_bind | 7.21e-04 | 7 | 111 | 2 | PF04818 | |
| Domain | IG | DSCAM PTPRU SEMA4C HMCN2 KIR3DL3 ROBO2 KIR3DL1 KIR3DL2 KIR3DS1 | 9.19e-04 | 421 | 111 | 9 | SM00409 |
| Domain | Ig_sub | DSCAM PTPRU SEMA4C HMCN2 KIR3DL3 ROBO2 KIR3DL1 KIR3DL2 KIR3DS1 | 9.19e-04 | 421 | 111 | 9 | IPR003599 |
| Domain | RPR | 9.57e-04 | 8 | 111 | 2 | SM00582 | |
| Domain | CID_dom | 9.57e-04 | 8 | 111 | 2 | IPR006569 | |
| Domain | CID | 9.57e-04 | 8 | 111 | 2 | PS51391 | |
| Domain | FERM_N | 9.79e-04 | 33 | 111 | 3 | IPR018979 | |
| Domain | FERM_N | 9.79e-04 | 33 | 111 | 3 | PF09379 | |
| Pathway | REACTOME_GLUCURONIDATION | 7.18e-11 | 24 | 85 | 7 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 9.92e-11 | 25 | 85 | 7 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 9.92e-11 | 25 | 85 | 7 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 9.92e-11 | 25 | 85 | 7 | M605 | |
| Pathway | WP_GLUCURONIDATION | 1.35e-10 | 26 | 85 | 7 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 2.41e-10 | 28 | 85 | 7 | M19580 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 SULT1C4 ABHD14B UGT1A4 UGT1A3 SULT6B1 | 9.69e-10 | 109 | 85 | 10 | M18788 |
| Pathway | WP_ESTROGEN_METABOLISM | 2.77e-09 | 22 | 85 | 6 | MM15888 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 4.29e-09 | 41 | 85 | 7 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 8.50e-09 | 45 | 85 | 7 | MM15694 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 ABHD14B UGT1A4 UGT1A3 SULT6B1 | 1.52e-08 | 107 | 85 | 9 | MM14595 |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 2.11e-08 | 51 | 85 | 7 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 2.42e-08 | 52 | 85 | 7 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 3.62e-08 | 55 | 85 | 7 | M14933 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.06e-07 | 64 | 85 | 7 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.99e-07 | 70 | 85 | 7 | M16794 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.36e-07 | 44 | 85 | 6 | M45014 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 2.42e-07 | 72 | 85 | 7 | M9257 | |
| Pathway | REACTOME_DRUG_ADME | 2.90e-07 | 109 | 85 | 8 | M45012 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 SULT1C4 ABHD14B UGT1A4 UGT1A3 SULT6B1 | 7.87e-07 | 220 | 85 | 10 | M10320 |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 2.55e-06 | 145 | 85 | 8 | M45512 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 3.80e-06 | 153 | 85 | 8 | MM15844 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 ABHD14B UGT1A4 UGT1A3 SULT6B1 | 6.62e-06 | 219 | 85 | 9 | MM14838 |
| Pathway | REACTOME_DRUG_ADME | 7.33e-06 | 119 | 85 | 7 | MM15692 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 1.42e-05 | 183 | 85 | 8 | M39588 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 7.34e-05 | 14 | 85 | 3 | M39328 | |
| Pathway | WP_OMEGA9_FATTY_ACID_SYNTHESIS | 7.34e-05 | 14 | 85 | 3 | M39780 | |
| Pathway | WP_OMEGA9_FATTY_ACID_SYNTHESIS | 7.34e-05 | 14 | 85 | 3 | MM15840 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 8.62e-05 | 39 | 85 | 4 | MM15695 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 9.14e-05 | 15 | 85 | 3 | MM15697 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 1.52e-04 | 45 | 85 | 4 | M39615 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.80e-04 | 47 | 85 | 4 | M29777 | |
| Pathway | REACTOME_HEME_DEGRADATION | 2.24e-04 | 20 | 85 | 3 | MM14721 | |
| Pathway | REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES | 2.29e-04 | 50 | 85 | 4 | M27282 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 2.60e-04 | 21 | 85 | 3 | M39631 | |
| Pathway | REACTOME_PREDNISONE_ADME | 3.43e-04 | 23 | 85 | 3 | MM16639 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 3.91e-04 | 24 | 85 | 3 | M16289 | |
| Pathway | WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2 | 5.31e-04 | 6 | 85 | 2 | M42575 | |
| Pathway | WP_ARYLAMINE_METABOLISM | 5.31e-04 | 6 | 85 | 2 | M39437 | |
| Pathway | WP_NICOTINE_METABOLISM_IN_LIVER_CELLS | 5.31e-04 | 6 | 85 | 2 | M39600 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 6.90e-04 | 29 | 85 | 3 | M45015 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 9.25e-04 | 32 | 85 | 3 | MM14719 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 1.26e-03 | 9 | 85 | 2 | MM15030 | |
| Pubmed | 1.21e-16 | 9 | 114 | 7 | 22511988 | ||
| Pubmed | 4.01e-16 | 10 | 114 | 7 | 23642732 | ||
| Pubmed | 4.01e-16 | 10 | 114 | 7 | 11465080 | ||
| Pubmed | 4.01e-16 | 10 | 114 | 7 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 4.01e-16 | 10 | 114 | 7 | 22558097 | |
| Pubmed | 2.63e-15 | 12 | 114 | 7 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 2.63e-15 | 12 | 114 | 7 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 5.69e-15 | 13 | 114 | 7 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 5.69e-15 | 13 | 114 | 7 | 25246029 | |
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 7.58e-15 | 7 | 114 | 6 | 8467709 | |
| Pubmed | 7.58e-15 | 7 | 114 | 6 | 8464825 | ||
| Pubmed | 1.14e-14 | 14 | 114 | 7 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 1.14e-14 | 14 | 114 | 7 | 10836148 | |
| Pubmed | 1.14e-14 | 14 | 114 | 7 | 9295054 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 1.14e-14 | 14 | 114 | 7 | 14672974 | |
| Pubmed | 3.02e-14 | 8 | 114 | 6 | 20610558 | ||
| Pubmed | 3.02e-14 | 8 | 114 | 6 | 17179145 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 3.76e-14 | 16 | 114 | 7 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 6.38e-14 | 17 | 114 | 7 | 20639394 | |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 1.64e-13 | 19 | 114 | 7 | 23281178 | |
| Pubmed | 3.46e-13 | 5 | 114 | 5 | 15057901 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 9.87e-13 | 12 | 114 | 6 | 20308471 | |
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 1.11e-12 | 24 | 114 | 7 | 24625756 | |
| Pubmed | 1.92e-11 | 8 | 114 | 5 | 18052087 | ||
| Pubmed | 1.95e-11 | 18 | 114 | 6 | 20056724 | ||
| Pubmed | 4.32e-11 | 9 | 114 | 5 | 1339448 | ||
| Pubmed | 1.09e-10 | 4 | 114 | 4 | 9271343 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 7.79e-10 | 57 | 114 | 7 | 21886157 | |
| Pubmed | 1.63e-09 | 6 | 114 | 4 | 32527940 | ||
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 1.63e-09 | 6 | 114 | 4 | 19204906 | |
| Pubmed | 1.63e-09 | 6 | 114 | 4 | 20297805 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 JMJD1C UGT1A4 UGT1A3 RBM5 FADS2 | 2.14e-09 | 211 | 114 | 10 | 24097068 |
| Pubmed | 2.24e-09 | 66 | 114 | 7 | 19898482 | ||
| Pubmed | 3.80e-09 | 7 | 114 | 4 | 27514509 | ||
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 7.59e-09 | 8 | 114 | 4 | 12695355 | |
| Pubmed | QPCTL MYO5A TRIM26 CNOT10 TNRC6B SRPRA YWHAG SEMA4C FARP2 PCF11 HDAC3 JUNB SLC9A1 WIZ RRS1 TLN1 RBM5 KMT2A ANKRD17 MARK2 TAF1L | 1.67e-08 | 1497 | 114 | 21 | 31527615 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ATMIN HIVEP2 BCL9 DCTN1 FOCAD JUNB FASN WIZ RRS1 ZNF408 TLN1 SBF2 NAV1 CPSF1 KCTD15 AKAP13 PRKDC RASD2 | 2.14e-08 | 1105 | 114 | 18 | 35748872 |
| Pubmed | Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. | 3.43e-08 | 3 | 114 | 3 | 11859120 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 12847094 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 29519853 | ||
| Pubmed | Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis. | 3.43e-08 | 3 | 114 | 3 | 19019897 | |
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia]. | 5.31e-08 | 12 | 114 | 4 | 17490516 | |
| Pubmed | 1.07e-07 | 14 | 114 | 4 | 19875891 | ||
| Pubmed | 1.07e-07 | 14 | 114 | 4 | 19489269 | ||
| Pubmed | Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. | 1.07e-07 | 14 | 114 | 4 | 15896204 | |
| Pubmed | 1.07e-07 | 14 | 114 | 4 | 18945962 | ||
| Pubmed | Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population. | 1.37e-07 | 4 | 114 | 3 | 18223459 | |
| Pubmed | Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1. | 1.37e-07 | 4 | 114 | 3 | 27455421 | |
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 9535849 | ||
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 17558305 | ||
| Pubmed | 1.45e-07 | 15 | 114 | 4 | 20082646 | ||
| Pubmed | 1.45e-07 | 15 | 114 | 4 | 20356536 | ||
| Pubmed | 1.45e-07 | 15 | 114 | 4 | 19926642 | ||
| Pubmed | 1.45e-07 | 15 | 114 | 4 | 20643584 | ||
| Pubmed | 1.45e-07 | 15 | 114 | 4 | 19326408 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK17 HIVEP2 YWHAG STIM1 PTPN14 MTUS1 ARHGEF10 STARD9 NAV1 KMT2A ANKRD17 AKAP13 SSH2 MARK2 MAP2K1 | 1.53e-07 | 861 | 114 | 15 | 36931259 |
| Pubmed | 1.93e-07 | 16 | 114 | 4 | 19897003 | ||
| Pubmed | 1.93e-07 | 16 | 114 | 4 | 19000141 | ||
| Pubmed | 1.93e-07 | 16 | 114 | 4 | 20670355 | ||
| Pubmed | 1.93e-07 | 16 | 114 | 4 | 18668235 | ||
| Pubmed | 1.93e-07 | 16 | 114 | 4 | 19309280 | ||
| Pubmed | Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage. | 1.93e-07 | 16 | 114 | 4 | 19527230 | |
| Pubmed | 1.93e-07 | 16 | 114 | 4 | 20652381 | ||
| Pubmed | 1.93e-07 | 16 | 114 | 4 | 19279038 | ||
| Pubmed | 1.93e-07 | 16 | 114 | 4 | 17868255 | ||
| Pubmed | 1.93e-07 | 16 | 114 | 4 | 18643961 | ||
| Pubmed | 1.93e-07 | 16 | 114 | 4 | 20331834 | ||
| Pubmed | 1.93e-07 | 16 | 114 | 4 | 20210919 | ||
| Pubmed | 2.30e-07 | 190 | 114 | 8 | 24816252 | ||
| Pubmed | 2.52e-07 | 17 | 114 | 4 | 19968064 | ||
| Pubmed | Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. | 2.52e-07 | 17 | 114 | 4 | 20878400 | |
| Pubmed | 2.52e-07 | 17 | 114 | 4 | 20650299 | ||
| Pubmed | 2.52e-07 | 17 | 114 | 4 | 19032228 | ||
| Pubmed | 2.52e-07 | 17 | 114 | 4 | 20173792 | ||
| Pubmed | 2.52e-07 | 17 | 114 | 4 | 20483367 | ||
| Pubmed | [Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese]. | 2.52e-07 | 17 | 114 | 4 | 19218127 | |
| Pubmed | 2.52e-07 | 17 | 114 | 4 | 19450876 | ||
| Pubmed | 2.52e-07 | 17 | 114 | 4 | 19761533 | ||
| Pubmed | Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. | 3.23e-07 | 18 | 114 | 4 | 19630074 | |
| Pubmed | Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians. | 3.23e-07 | 18 | 114 | 4 | 19046302 | |
| Pubmed | 3.23e-07 | 18 | 114 | 4 | 20580654 | ||
| Pubmed | 3.23e-07 | 18 | 114 | 4 | 20519398 | ||
| Pubmed | 3.23e-07 | 18 | 114 | 4 | 19846535 | ||
| Pubmed | 3.23e-07 | 18 | 114 | 4 | 20210918 | ||
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 20565459 | ||
| Pubmed | KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. | 4.09e-07 | 19 | 114 | 4 | 18571006 | |
| Pubmed | Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil. | 4.09e-07 | 19 | 114 | 4 | 18778326 | |
| Pubmed | 4.09e-07 | 19 | 114 | 4 | 20600442 | ||
| Pubmed | 4.09e-07 | 19 | 114 | 4 | 18848853 | ||
| Pubmed | Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. | 5.09e-07 | 20 | 114 | 4 | 20193031 | |
| Pubmed | 5.09e-07 | 20 | 114 | 4 | 20426625 | ||
| Pubmed | 6.28e-07 | 21 | 114 | 4 | 19861144 | ||
| Pubmed | 7.65e-07 | 22 | 114 | 4 | 20492596 | ||
| Pubmed | 1.19e-06 | 7 | 114 | 3 | 12618911 | ||
| Pubmed | Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint. | 1.19e-06 | 7 | 114 | 3 | 20818375 | |
| Pubmed | Expression of a killer cell receptor-like gene in plastic regions of the central nervous system. | 1.19e-06 | 7 | 114 | 3 | 15748957 | |
| Pubmed | 1.55e-06 | 26 | 114 | 4 | 36178190 | ||
| Pubmed | 1.59e-06 | 332 | 114 | 9 | 37433992 | ||
| Pubmed | CDK17 QPCTL MYO5A SRPRA DCTN1 PCF11 STIM1 ARHGAP1 PTPN14 ARHGEF10 RRS1 TLN1 LRRC1 VPS13A FADS2 AKAP13 MARK2 MAP2K1 | 1.67e-06 | 1487 | 114 | 18 | 33957083 | |
| Pubmed | DSCAM TNRC6B SRPRA SEMA4C PCF11 STIM1 ARHGAP1 WIZ VPS13A RBM5 TJAP1 PRKDC PLD1 | 1.71e-06 | 777 | 114 | 13 | 35844135 | |
| Interaction | TAFA2 interactions | 2.42e-07 | 47 | 113 | 6 | int:TAFA2 | |
| Interaction | UGT1A7 interactions | 1.68e-05 | 57 | 113 | 5 | int:UGT1A7 | |
| Interaction | RAB35 interactions | MYO5A SRPRA DCTN1 SEMA4C STIM1 ARHGAP1 SLC9A1 PTPN14 ARHGEF10 SBF2 VPS13A PLD1 MARK2 | 1.98e-05 | 573 | 113 | 13 | int:RAB35 |
| Interaction | ZC3H7A interactions | 2.89e-05 | 215 | 113 | 8 | int:ZC3H7A | |
| Interaction | THRA interactions | 3.82e-05 | 111 | 113 | 6 | int:THRA | |
| Interaction | UGT1A9 interactions | 4.71e-05 | 13 | 113 | 3 | int:UGT1A9 | |
| Interaction | YWHAQ interactions | CDK17 HIVEP2 YWHAG HDAC3 FASN PTPN14 MTUS1 STARD9 TLN1 NAV1 KCTD15 KMT2A ANKRD17 AKAP13 PRKDC SSH2 MARK2 MAP2K1 | 4.86e-05 | 1118 | 113 | 18 | int:YWHAQ |
| Interaction | LYN interactions | CNOT10 IRAK2 SEMA4C FARP2 HDAC3 PTPN14 LRRC1 VPS13A TRIM63 KMT2A ROBO2 PRKDC PLD1 MARK2 | 5.08e-05 | 720 | 113 | 14 | int:LYN |
| Interaction | TOP3B interactions | ATMIN HIVEP2 CNOT10 TNRC6B BCL9 DCTN1 FOCAD JUNB FASN WIZ RRS1 ZNF408 TLN1 SBF2 NAV1 CPSF1 KCTD15 ANKRD17 AKAP13 PRKDC RASD2 | 6.09e-05 | 1470 | 113 | 21 | int:TOP3B |
| Interaction | APC interactions | COPS2 DCTN1 YWHAG WIZ ZNF408 NAV1 ANKRD17 AKAP13 MARK2 MAP2K1 | 6.79e-05 | 389 | 113 | 10 | int:APC |
| Interaction | ARHGEF28 interactions | 8.90e-05 | 42 | 113 | 4 | int:ARHGEF28 | |
| Interaction | UGT1A8 interactions | 9.31e-05 | 3 | 113 | 2 | int:UGT1A8 | |
| Cytoband | 2q37 | 1.21e-12 | 31 | 114 | 7 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 FARP2 UGT1A4 UGT1A3 KLHL30 | 5.99e-09 | 226 | 114 | 9 | chr2q37 |
| GeneFamily | UDP glucuronosyltransferases | 7.82e-11 | 32 | 80 | 7 | 363 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 1.04e-06 | 18 | 80 | 4 | 620 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.41e-03 | 50 | 80 | 3 | 1293 | |
| GeneFamily | Sulfotransferases, cytosolic | 1.70e-03 | 14 | 80 | 2 | 762 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.12e-03 | 66 | 80 | 3 | 722 | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 2.70e-08 | 187 | 113 | 8 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.31e-07 | 193 | 113 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | CV-Healthy-3|CV / Virus stimulation, Condition and Cluster | 3.52e-06 | 161 | 113 | 6 | fd4a79385ea967b9900dc76a3add813b894a3a28 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-06 | 170 | 113 | 6 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-06 | 192 | 113 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.95e-06 | 193 | 113 | 6 | ba484fa1f290a92ae02475a4c468b4ac840c133e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.06e-05 | 195 | 113 | 6 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | ASK440-Epithelial-Type_2|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.12e-05 | 197 | 113 | 6 | 08d5bbeb77a4152af1c783bc958afcae24667767 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-05 | 199 | 113 | 6 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | ASK428-Epithelial-Type_2|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.22e-05 | 200 | 113 | 6 | 8919d7371b9d9a061d52664532980c6ea20d0473 | |
| ToppCell | lung-Type_II_Pneumocytes|lung / shred on tissue and cell subclass | 3.68e-05 | 147 | 113 | 5 | 8a3039de45b8087f8319e2e37329acf7278219b7 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.18e-05 | 151 | 113 | 5 | 8ba15ab24fe2e71df0a2a7511ca451ad2376bd91 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-05 | 151 | 113 | 5 | ea62e92ccb984f44559b434f35c1c4450767c8f1 | |
| ToppCell | CV-Healthy-3|Healthy / Virus stimulation, Condition and Cluster | 4.59e-05 | 154 | 113 | 5 | 26bf81a86700db7e65c2384ffe94ed4253ea4047 | |
| ToppCell | (08)_PNEC-(1)_24hpi|(08)_PNEC / shred by cell type and Timepoint | 5.37e-05 | 29 | 113 | 3 | f1b59a0b6bce5772bfb084f08507cf775e7eae8c | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.96e-05 | 173 | 113 | 5 | 79d11f94a8f6a420c18c2fef0da77e9af3204765 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.60e-05 | 180 | 113 | 5 | d33bb00f2b7d07dda9015cb8eafd742c2b2e9ace | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.60e-05 | 180 | 113 | 5 | 2658a6be43d6d94767b4fc5af2d8632469a8a979 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-05 | 181 | 113 | 5 | 57f0cc749ae8b6a3d77e2af31f9a6e4739c57049 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 9.85e-05 | 181 | 113 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-05 | 181 | 113 | 5 | d01b35cc2fc57991a35be6a06cb7351fbabd9a11 | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-04 | 184 | 113 | 5 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-04 | 185 | 113 | 5 | 8ca1374501eca01d8468130b74d50abfd4329fbe | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.18e-04 | 188 | 113 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | IPF-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 1.18e-04 | 188 | 113 | 5 | 5f5fad2773e421760e67dbace23fd1f847a2e1e0 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 188 | 113 | 5 | 5e13725136114e42d3b59647cf25e0f3c53abb54 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 189 | 113 | 5 | 1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 192 | 113 | 5 | c47df468cf78a90929913c9022e8078a53cdf680 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-04 | 193 | 113 | 5 | 8646e573f2d2ff175f3d02bfdf214e65f3b614d3 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-04 | 193 | 113 | 5 | 043dd0fc2f93e0bd1ca34ac3e196622b3e91df0f | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.33e-04 | 193 | 113 | 5 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | Control-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 1.36e-04 | 194 | 113 | 5 | a01de094f7bfd099bcbb2f94224690a2efb887b4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.40e-04 | 195 | 113 | 5 | 6617abca0009ad3d8731f515f91ab275f9ea4c40 | |
| ToppCell | normal_Lung-Epithelial_cells-AT2|Epithelial_cells / Location, Cell class and cell subclass | 1.40e-04 | 195 | 113 | 5 | 81e13fe337f1d0a83d0deb86a0df797d306cd24d | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT2-AT2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.40e-04 | 195 | 113 | 5 | 6867f9c56ea27a17c8c4099aae0d79903c3748a5 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.40e-04 | 195 | 113 | 5 | fc0ae145a2118df7cbbc9ac4ca9dc12d26c087c4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.40e-04 | 195 | 113 | 5 | d9694db6bf239636d1335016878c98f6ee2eb0eb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-04 | 195 | 113 | 5 | d35102f95bb1e419d2df05ff0a01b6c5c923acef | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.40e-04 | 195 | 113 | 5 | 955a0a7244cd7eaf006a39e1bd03333baf6f30a4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-04 | 196 | 113 | 5 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-04 | 196 | 113 | 5 | 82b117be41f2e7d677a42d2a5198726eeccb16d0 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.43e-04 | 196 | 113 | 5 | a7cbe66ebd8931ef2b8ff26a42afce0ad1c48f17 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-04 | 196 | 113 | 5 | 65e161fd672e37a5d10f28011bb422c4d7042d6a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-04 | 196 | 113 | 5 | 006d783a530aa6e1e6545dcc2e6b00bb300fe070 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-04 | 197 | 113 | 5 | 0de77f04612b66cc637dab5d5432c6e711e5964e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-04 | 197 | 113 | 5 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | 356C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-04 | 197 | 113 | 5 | a01640e31fc33c1ab512b4d3eddae8342ecf182c | |
| ToppCell | ASK428-Epithelial-Type_2|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.50e-04 | 198 | 113 | 5 | ec0d1801363adb70c6a26655b79d12b438c7417d | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-A_(AT2)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.53e-04 | 199 | 113 | 5 | 09cf004032e5af912ee0cdde6e24ce3bcf7673cd | |
| ToppCell | TCGA-Ovary-Primary_Tumor|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.54e-04 | 106 | 113 | 4 | 14f548be39cec604fbdae0382cbf434fa4049840 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.54e-04 | 106 | 113 | 4 | 939b80950d39cdc7149a05fdfb64c8810064cdb1 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.54e-04 | 106 | 113 | 4 | e9e1b55f32b3d5b9eeec94a997912e5c21c1fb48 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.57e-04 | 200 | 113 | 5 | 316f42c61a172fc611a2043f30c76ed7c8a36210 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Hpcal4_(Substantia_Innominata_(SI))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.77e-04 | 43 | 113 | 3 | f1e6e1c386851e773f8aa44f112ebf7fdb887df1 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Hpcal4_(Substantia_Innominata_(SI))--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.77e-04 | 43 | 113 | 3 | 05de4f11e7315dce19efed14605d7e1704d61b3a | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Hpcal4_(Substantia_Innominata_(SI))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.77e-04 | 43 | 113 | 3 | ba1a8fd3119a26b65722898276045bf5ecf59768 | |
| Drug | AC1MRQNQ | 2.19e-15 | 9 | 113 | 7 | CID003522271 | |
| Drug | DHPASiU | 2.19e-15 | 9 | 113 | 7 | CID000197602 | |
| Drug | 3-iodophenol | 2.19e-15 | 9 | 113 | 7 | CID000012272 | |
| Drug | AC1L4J7U | 2.19e-15 | 9 | 113 | 7 | CID000186631 | |
| Drug | Chebi:32663 | 2.19e-15 | 9 | 113 | 7 | CID005460873 | |
| Drug | 4-nitrophenyl)imidazole | 1.99e-14 | 11 | 113 | 7 | CID000123155 | |
| Drug | AC1O5XMV | 1.99e-14 | 11 | 113 | 7 | CID006442661 | |
| Drug | N-OH-DABZ | 4.77e-14 | 12 | 113 | 7 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 4.77e-14 | 12 | 113 | 7 | CID000088735 | |
| Drug | 2,4,6-TCB | 4.77e-14 | 12 | 113 | 7 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 4.77e-14 | 12 | 113 | 7 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 4.77e-14 | 12 | 113 | 7 | CID000276709 | |
| Drug | tritanol | 1.03e-13 | 13 | 113 | 7 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 1.03e-13 | 13 | 113 | 7 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 1.03e-13 | 13 | 113 | 7 | CID000000411 | |
| Drug | propranolol glucuronide | 2.05e-13 | 14 | 113 | 7 | CID000119515 | |
| Drug | PCB-61 | 2.05e-13 | 14 | 113 | 7 | CID000036401 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 3.83e-13 | 15 | 113 | 7 | CID000040469 | |
| Drug | afloqualone | 3.83e-13 | 15 | 113 | 7 | CID000002040 | |
| Drug | naphthyl sulphate | 3.83e-13 | 15 | 113 | 7 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 3.83e-13 | 15 | 113 | 7 | CID000010752 | |
| Drug | sulforaphane nitrile | 3.83e-13 | 15 | 113 | 7 | CID000543743 | |
| Drug | quercetin-3,4'-diglucoside | 6.77e-13 | 16 | 113 | 7 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 6.77e-13 | 16 | 113 | 7 | CID000040003 | |
| Drug | bilirubin-phosphate | 6.77e-13 | 16 | 113 | 7 | CID005497144 | |
| Drug | erucin | 8.19e-13 | 28 | 113 | 8 | CID000078160 | |
| Drug | H-Ni | 8.19e-13 | 28 | 113 | 8 | CID000445665 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 1.15e-12 | 17 | 113 | 7 | CID000003573 | |
| Drug | 6-hydroxychrysene | 1.15e-12 | 17 | 113 | 7 | CID000037766 | |
| Drug | SureCN12722713 | 1.87e-12 | 18 | 113 | 7 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 1.87e-12 | 18 | 113 | 7 | CID000152226 | |
| Drug | Br 2 | 1.87e-12 | 18 | 113 | 7 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 1.87e-12 | 18 | 113 | 7 | CID000036614 | |
| Drug | ApApG | 1.87e-12 | 18 | 113 | 7 | CID003081975 | |
| Drug | C1 11-32 | 1.87e-12 | 18 | 113 | 7 | CID000443077 | |
| Drug | C11131 | 1.87e-12 | 18 | 113 | 7 | CID000443076 | |
| Drug | 9-OH-risperidone | 2.95e-12 | 19 | 113 | 7 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 2.95e-12 | 19 | 113 | 7 | CID000091433 | |
| Drug | almokalant | 2.95e-12 | 19 | 113 | 7 | CID003033962 | |
| Drug | (+/-)-Abacavir | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 LTA KIR3DL1 | 3.38e-12 | 51 | 113 | 9 | CID000001971 |
| Drug | 6-methylsalicylic acid | 3.58e-12 | 33 | 113 | 8 | CID000011279 | |
| Drug | tectochrysin | 4.52e-12 | 20 | 113 | 7 | CID005281954 | |
| Drug | AC1L1OBF | 4.52e-12 | 20 | 113 | 7 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 4.52e-12 | 20 | 113 | 7 | CID000116545 | |
| Drug | estriol-16-glucuronide | 6.75e-12 | 21 | 113 | 7 | CID000122281 | |
| Drug | dulcin | 6.75e-12 | 21 | 113 | 7 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 6.75e-12 | 21 | 113 | 7 | CID000069186 | |
| Drug | amonafide | 9.85e-12 | 22 | 113 | 7 | CID000050515 | |
| Drug | N-methylpiperazine | 9.85e-12 | 22 | 113 | 7 | CID000053167 | |
| Drug | amidoxime | 1.41e-11 | 23 | 113 | 7 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 1.41e-11 | 23 | 113 | 7 | CID000066651 | |
| Drug | phenanthridine | 1.41e-11 | 23 | 113 | 7 | CID000009189 | |
| Drug | AS-3201 | 1.98e-11 | 24 | 113 | 7 | CID000153948 | |
| Drug | 5-MOP | 2.74e-11 | 25 | 113 | 7 | CID000002355 | |
| Drug | AzMC | 2.74e-11 | 25 | 113 | 7 | CID000064986 | |
| Drug | N-acetylbenzidine | 2.74e-11 | 25 | 113 | 7 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 2.74e-11 | 25 | 113 | 7 | CID000006796 | |
| Drug | N-phenylmaleimide | 2.74e-11 | 25 | 113 | 7 | CID000013662 | |
| Drug | 7,8-benzoquinoline | 3.59e-11 | 43 | 113 | 8 | CID000009191 | |
| Drug | anthraflavic acid | 4.37e-11 | 44 | 113 | 8 | CID000006776 | |
| Drug | diflunisal | 5.03e-11 | 27 | 113 | 7 | CID000003059 | |
| Drug | DiMeIQx | 5.03e-11 | 27 | 113 | 7 | CID000104739 | |
| Drug | CARMINE | 6.68e-11 | 28 | 113 | 7 | CID000014749 | |
| Drug | N-hydroxy-4-aminobiphenyl | 6.68e-11 | 28 | 113 | 7 | CID000081261 | |
| Drug | AC1L1JAL | 8.76e-11 | 29 | 113 | 7 | CID000004954 | |
| Drug | 7-hydroxycoumarin glucuronide | 8.76e-11 | 29 | 113 | 7 | CID000125641 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 8.76e-11 | 29 | 113 | 7 | CID005375667 | |
| Drug | trans-3'-hydroxycotinine | 8.76e-11 | 29 | 113 | 7 | CID000000414 | |
| Drug | iberin | 8.76e-11 | 29 | 113 | 7 | CID000010455 | |
| Drug | tolcapone | 1.14e-10 | 30 | 113 | 7 | CID004659569 | |
| Drug | paricalcitol | 1.14e-10 | 30 | 113 | 7 | CID005281104 | |
| Drug | AC1L9E0Q | 1.14e-10 | 30 | 113 | 7 | CID000443095 | |
| Drug | dihydroartemisinin | 1.14e-10 | 30 | 113 | 7 | CID000107770 | |
| Drug | PCB 156 | 1.46e-10 | 31 | 113 | 7 | CID000038019 | |
| Drug | 4'-HPPH | 1.46e-10 | 31 | 113 | 7 | CID000017732 | |
| Drug | 4-ethylphenol | 1.46e-10 | 31 | 113 | 7 | CID000031242 | |
| Drug | Muracein C | 1.87e-10 | 32 | 113 | 7 | CID003086323 | |
| Drug | indole-2-carboxylic acid | 1.87e-10 | 32 | 113 | 7 | CID000072899 | |
| Drug | NNAL | 1.87e-10 | 32 | 113 | 7 | CID000104856 | |
| Drug | R(-)-Denopamine | 2.36e-10 | 33 | 113 | 7 | CID000003818 | |
| Drug | norbuprenorphine | 2.36e-10 | 33 | 113 | 7 | CID000114976 | |
| Drug | AC1Q6OQG | 2.36e-10 | 33 | 113 | 7 | CID000009686 | |
| Drug | BP-3,6-quinol | 2.36e-10 | 33 | 113 | 7 | CID000119292 | |
| Drug | geniposide | 2.36e-10 | 33 | 113 | 7 | CID000107848 | |
| Drug | estragole | 2.96e-10 | 34 | 113 | 7 | CID000008815 | |
| Drug | Invader | 3.34e-10 | 56 | 113 | 8 | CID006442259 | |
| Drug | AC1NOWCJ | 3.68e-10 | 35 | 113 | 7 | CID005120112 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 3.68e-10 | 35 | 113 | 7 | CID010436171 | |
| Drug | estrone-3-glucuronide | 3.68e-10 | 35 | 113 | 7 | CID000115255 | |
| Drug | muraglitazar | 4.56e-10 | 36 | 113 | 7 | CID000206044 | |
| Drug | glucoraphanin | 4.56e-10 | 36 | 113 | 7 | CID000656556 | |
| Drug | AC1L9DGV | 4.56e-10 | 36 | 113 | 7 | CID000417381 | |
| Drug | anisole | 4.56e-10 | 36 | 113 | 7 | CID000007519 | |
| Drug | bevirimat | 4.56e-10 | 36 | 113 | 7 | CID000457928 | |
| Drug | acotiamide | 5.60e-10 | 37 | 113 | 7 | CID005282338 | |
| Drug | 6beta-hydroxytestosterone | 5.60e-10 | 37 | 113 | 7 | CID000065543 | |
| Drug | N-Fg | 5.60e-10 | 37 | 113 | 7 | CID000445227 | |
| Drug | l-borneol | 5.60e-10 | 37 | 113 | 7 | CID000010049 | |
| Drug | hydratropic acid | 5.75e-10 | 4 | 113 | 4 | ctd:C013025 | |
| Drug | 2-vanillin | 5.75e-10 | 4 | 113 | 4 | ctd:C060843 | |
| Disease | biliverdin measurement | 1.52e-17 | 12 | 111 | 8 | EFO_0021033 | |
| Disease | X-11793--oxidized bilirubin measurement | 7.01e-17 | 8 | 111 | 7 | EFO_0021260 | |
| Disease | Succinimide measurement | 7.01e-17 | 8 | 111 | 7 | EFO_0022118 | |
| Disease | X-11530 measurement | 7.01e-17 | 8 | 111 | 7 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 7.01e-17 | 8 | 111 | 7 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 7.01e-17 | 8 | 111 | 7 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 7.01e-17 | 8 | 111 | 7 | EFO_0800696 | |
| Disease | X-10458 measurement | 7.01e-17 | 8 | 111 | 7 | EFO_0800692 | |
| Disease | X-24849 measurement | 7.01e-17 | 8 | 111 | 7 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 7.01e-17 | 8 | 111 | 7 | EFO_0802740 | |
| Disease | X-16946 measurement | 7.01e-17 | 8 | 111 | 7 | EFO_0800766 | |
| Disease | X-11442 measurement | 3.15e-16 | 9 | 111 | 7 | EFO_0021236 | |
| Disease | X-11441 measurement | 3.15e-16 | 9 | 111 | 7 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 3.15e-16 | 9 | 111 | 7 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 3.15e-16 | 9 | 111 | 7 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 3.15e-16 | 9 | 111 | 7 | EFO_0801036 | |
| Disease | X-11880 measurement | 3.15e-16 | 9 | 111 | 7 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 3.15e-16 | 9 | 111 | 7 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 3.15e-16 | 9 | 111 | 7 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 3.15e-16 | 9 | 111 | 7 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 1.05e-15 | 10 | 111 | 7 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 1.05e-15 | 10 | 111 | 7 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 1.05e-15 | 10 | 111 | 7 | EFO_0802185 | |
| Disease | X-23974 measurement | 1.05e-15 | 10 | 111 | 7 | EFO_0800867 | |
| Disease | histidine betaine (hercynine) measurement | 2.87e-15 | 11 | 111 | 7 | EFO_0800972 | |
| Disease | X-21796 measurement | 2.87e-15 | 11 | 111 | 7 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 2.87e-15 | 11 | 111 | 7 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 2.87e-15 | 11 | 111 | 7 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 6.86e-15 | 12 | 111 | 7 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 1.48e-14 | 13 | 111 | 7 | EFO_0802007 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.66e-13 | 17 | 111 | 7 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 2.71e-13 | 18 | 111 | 7 | EFO_0801382 | |
| Disease | gallstones | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 TNRC6B JMJD1C FARP2 UGT1A4 UGT1A3 FADS2 | 3.27e-13 | 108 | 111 | 11 | EFO_0004210 |
| Disease | tissue factor measurement | 9.79e-13 | 21 | 111 | 7 | EFO_0010623 | |
| Disease | pregnenetriol sulfate measurement | 1.12e-12 | 11 | 111 | 6 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 1.12e-12 | 11 | 111 | 6 | EFO_0600039 | |
| Disease | cholelithiasis | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 TNRC6B JMJD1C UGT1A4 UGT1A3 FADS2 | 1.33e-12 | 88 | 111 | 10 | EFO_0004799 |
| Disease | pregnenetriol disulfate measurement | 4.15e-12 | 13 | 111 | 6 | EFO_0800587 | |
| Disease | xanthurenate measurement | 1.28e-11 | 29 | 111 | 7 | EFO_0010551 | |
| Disease | response to dolutegravir | 1.67e-11 | 30 | 111 | 7 | EFO_0600017 | |
| Disease | X-21441 measurement | 2.96e-11 | 17 | 111 | 6 | EFO_0800814 | |
| Disease | serum N-desmethylclozapine measurement | 3.82e-11 | 8 | 111 | 5 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 3.82e-11 | 8 | 111 | 5 | EFO_0600038 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 9.46e-10 | 5 | 111 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 9.46e-10 | 5 | 111 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 9.46e-10 | 5 | 111 | 4 | EFO_0801853 | |
| Disease | thyroxine measurement | 9.69e-10 | 83 | 111 | 8 | EFO_0005130 | |
| Disease | urate measurement, spine bone mineral density | 2.26e-09 | 58 | 111 | 7 | EFO_0004531, EFO_0007701 | |
| Disease | X-21339 measurement | 6.58e-09 | 7 | 111 | 4 | EFO_0800808 | |
| Disease | hormone measurement | 3.14e-08 | 84 | 111 | 7 | EFO_0004730 | |
| Disease | indole-3-carboxylate measurement | 5.18e-08 | 3 | 111 | 3 | EFO_0800043 | |
| Disease | blood 4-oxo-retinoic acid measurement | 5.18e-08 | 3 | 111 | 3 | EFO_0022216 | |
| Disease | Adenocarcinoma of lung (disorder) | 9.04e-08 | 206 | 111 | 9 | C0152013 | |
| Disease | X-24588 measurement | 1.32e-07 | 13 | 111 | 4 | EFO_0800898 | |
| Disease | vitamin D deficiency | 2.72e-07 | 37 | 111 | 5 | EFO_0003762 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 1.03e-06 | 6 | 111 | 3 | EFO_0800566 | |
| Disease | vitamin D measurement, COVID-19 | 1.15e-06 | 49 | 111 | 5 | EFO_0004631, MONDO_0100096 | |
| Disease | neuroblastoma, cutaneous melanoma | 3.62e-06 | 28 | 111 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | indoleacetate measurement | 6.10e-06 | 10 | 111 | 3 | EFO_0021015 | |
| Disease | neutrophil count | PRPSAP1 HIVEP2 DSCAM NEIL2 TEX14 BCL9 JMJD1C FARP2 SLC9A1 PTPN14 SBF2 SULT6B1 FADS2 AKAP13 LTA PRKDC SSH2 | 1.60e-05 | 1382 | 111 | 17 | EFO_0004833 |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 2.03e-05 | 147 | 111 | 6 | DOID:9352 (biomarker_via_orthology) | |
| Disease | bilirubin measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 JMJD1C UGT1A4 UGT1A3 FADS2 | 4.59e-05 | 442 | 111 | 9 | EFO_0004570 |
| Disease | metabolite measurement | DSCAM UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 FADS2 ACOT2 | 5.19e-05 | 560 | 111 | 10 | EFO_0004725 |
| Disease | testosterone measurement | PCSK1 QPCTL DSCAM MYO5A UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 JMJD1C FARP2 UGT1A4 FASN SUSD1 SBF2 | 8.74e-05 | 1275 | 111 | 15 | EFO_0004908 |
| Disease | free androgen index | 8.77e-05 | 374 | 111 | 8 | EFO_0007005 | |
| Disease | Schizophrenia | BCL9 GRM4 UGT1A3 ARHGAP1 HDAC3 CELF2 NAV1 FADS2 KMT2A LTA MARK2 RASD2 | 1.25e-04 | 883 | 111 | 12 | C0036341 |
| Disease | ovarian carcinoma (is_marker_for) | 1.58e-04 | 28 | 111 | 3 | DOID:4001 (is_marker_for) | |
| Disease | temporal horn of lateral ventricle volume measurement | 1.60e-04 | 72 | 111 | 4 | EFO_0010333 | |
| Disease | serum gamma-glutamyl transferase measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A9 JMJD1C FARP2 CELF2 RRS1 TLN1 KMT2A AKAP13 TAL1 | 1.72e-04 | 914 | 111 | 12 | EFO_0004532 |
| Disease | apolipoprotein B measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 SRPRA FARP2 UGT1A4 UGT1A3 FADS2 | 2.06e-04 | 663 | 111 | 10 | EFO_0004615 |
| Disease | level of Sphingomyelin (d36:2) in blood serum | 2.91e-04 | 7 | 111 | 2 | OBA_2045177 | |
| Disease | non-high density lipoprotein cholesterol measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 TRIM63 FADS2 MARK2 | 3.67e-04 | 713 | 111 | 10 | EFO_0005689 |
| Disease | osteosarcoma | 3.87e-04 | 8 | 111 | 2 | EFO_0000637 | |
| Disease | red blood cell density measurement | ATR TNRC6B ACAD10 JMJD1C FARP2 FOCAD KLHL30 SBF2 FADS2 AKAP13 SSH2 | 4.91e-04 | 880 | 111 | 11 | EFO_0007978 |
| Disease | Combined immunodeficiency | 4.98e-04 | 41 | 111 | 3 | C0494261 | |
| Disease | lung adenocarcinoma | 5.21e-04 | 174 | 111 | 5 | EFO_0000571 | |
| Disease | urate measurement, bone density | 5.62e-04 | 619 | 111 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | reticulocyte measurement | PRPSAP1 ATR TNRC6B JMJD1C GARIN2 WIZ SUSD1 SBF2 VPS13A AKAP13 C4BPA PLD1 | 6.16e-04 | 1053 | 111 | 12 | EFO_0010700 |
| Disease | pulse pressure measurement | QPCTL DSCAM TNRC6B ACAD10 GRM4 FASN CELF2 SBF2 LRRC1 SULT6B1 NAV1 FADS2 AKAP13 LTA | 7.39e-04 | 1392 | 111 | 14 | EFO_0005763 |
| Disease | motor function measurement | 7.54e-04 | 11 | 111 | 2 | EFO_0010749 | |
| Disease | insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation | 7.54e-04 | 11 | 111 | 2 | EFO_0004471, EFO_0009131 | |
| Disease | fasting blood glucose measurement | 7.75e-04 | 287 | 111 | 6 | EFO_0004465 | |
| Disease | dodecanedioate measurement | 9.03e-04 | 12 | 111 | 2 | EFO_0021054 | |
| Disease | body weight | SECISBP2L PCSK1 CDK17 HIVEP2 TNRC6B FASN PTPN14 SUSD1 FEZF1 ADAMTS17 KCTD15 FADS2 TAL1 | 9.21e-04 | 1261 | 111 | 13 | EFO_0004338 |
| Disease | mean corpuscular hemoglobin concentration | ATMIN ATR TNRC6B ACAD10 FOCAD RPRD1A SUSD1 VPS13A FADS2 AKAP13 PRKDC TAL1 | 9.37e-04 | 1105 | 111 | 12 | EFO_0004528 |
| Disease | Fulminant Hepatic Failure with Cerebral Edema | 1.06e-03 | 13 | 111 | 2 | C0751197 | |
| Disease | Hepatic Stupor | 1.06e-03 | 13 | 111 | 2 | C0751198 | |
| Disease | level of Sphingomyelin (d34:2) in blood serum | 1.06e-03 | 13 | 111 | 2 | OBA_2045174 | |
| Disease | Hepatic Encephalopathy | 1.06e-03 | 13 | 111 | 2 | C0019151 | |
| Disease | Hepatic Coma | 1.06e-03 | 13 | 111 | 2 | C0019147 | |
| Disease | lobe attachment | 1.14e-03 | 207 | 111 | 5 | EFO_0007667 | |
| Disease | lobe size | 1.24e-03 | 14 | 111 | 2 | EFO_0007666 | |
| Disease | polyp of colon | 1.24e-03 | 56 | 111 | 3 | MONDO_0021400 | |
| Disease | Hypertrophic Cardiomyopathy | 1.31e-03 | 57 | 111 | 3 | C0007194 | |
| Disease | phosphatidylcholine 36:3 measurement | 1.43e-03 | 15 | 111 | 2 | EFO_0010381 | |
| Disease | mean platelet volume | NHLRC1 HIVEP2 MYO5A SULT1C4 JMJD1C STIM1 CELF2 FADS2 C4BPA MAP2K1 TAL1 | 1.62e-03 | 1020 | 111 | 11 | EFO_0004584 |
| Disease | teratocarcinoma-derived growth factor 1 measurement | 1.63e-03 | 16 | 111 | 2 | EFO_0008297 | |
| Disease | infant expressive language ability | 1.63e-03 | 16 | 111 | 2 | EFO_0006316 | |
| Disease | ovarian neoplasm | 1.67e-03 | 134 | 111 | 4 | C0919267 | |
| Disease | vitamin D measurement | 1.73e-03 | 336 | 111 | 6 | EFO_0004631 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VMRHKGAPHLRPAAH | 466 | P35503 | |
| SKEHMQPTHPIRLGL | 161 | P61981 | |
| MHPPKTPSGALHRKR | 1 | P04003 | |
| PVHNMLPGHQRLSVT | 1151 | O15013 | |
| NALHNIKTLPGMHHP | 101 | O95319 | |
| SLHIKSAIPHPLIMG | 221 | P61201 | |
| GAQMKASLASLPPLH | 1116 | Q14203 | |
| LGKPKGHPHMNSIRI | 31 | Q14833 | |
| QVSHPHTKLMRIPSF | 2686 | Q12802 | |
| QFHGLTVPGPRHMAL | 221 | C9J069 | |
| MGKTDPHAPRHRQQS | 841 | Q6JQN1 | |
| MSNKLLSPHPHSVVL | 1 | P49753 | |
| PKPHMVPRHSNQNSS | 1941 | O75179 | |
| VQKQPAPHSHRMSPE | 146 | A6NLC5 | |
| QHTVRLPHKLPGMHY | 456 | Q8TE56 | |
| SHKPSGLVMARKLIH | 86 | Q02750 | |
| RHLAQLMESIPHSPG | 241 | Q9NXS2 | |
| MVTGNHRKPSLLAHP | 116 | P43630 | |
| APMLKPRTNHASAAL | 361 | Q0D2K2 | |
| PNHRVLIMKGAGHPC | 176 | Q96IU4 | |
| MPRHNLHKIAPLVKS | 391 | O95864 | |
| MPEGPLVRKFHHLVS | 1 | Q969S2 | |
| LAHPMAHLCPVNKRS | 351 | O43187 | |
| PLVSRAHVHLMKTPP | 846 | Q9ULD2 | |
| HMAFQKVPRPTEGSH | 471 | Q86WG5 | |
| AHLMCNVTGHPQPKL | 2471 | Q8NDA2 | |
| PHDHKHLMPTQIIPG | 1896 | Q15652 | |
| LTTMLPHHAGLNPRA | 1366 | Q10570 | |
| MVTGNHRKPSLLAHP | 116 | P43629 | |
| MVTGVHRKPSLLAHP | 116 | Q8N743 | |
| PIVKNGRPPTSHSMH | 41 | Q00537 | |
| NPLHHPTIMTSKLCL | 126 | Q8NH79 | |
| IQGKHIAMHYSNPRP | 166 | P52756 | |
| GHPMKPHRLALTHSL | 21 | O15379 | |
| LRRATPHPGELKHMK | 476 | Q9BTT6 | |
| DRHRVKLHPMLGDPN | 926 | Q92729 | |
| MKHKRQTQHREPPDG | 196 | P14652 | |
| LHVSQIPPMAVKAPH | 256 | O94913 | |
| MIPTLPSILGTHANH | 2266 | Q13535 | |
| PNSPALNMHLVKSHR | 96 | O43313 | |
| PHNILISMPNAHGKI | 691 | O75460 | |
| HSPGINPLKSPTMHQ | 856 | O00512 | |
| MHLHVQPLRAKGKRP | 1 | P0C843 | |
| LRNHPVATLMATGHP | 421 | Q9NZK5 | |
| RPRQHQKSMSASVHP | 526 | Q7KZI7 | |
| FPSASKGLLPMSHHQ | 3146 | Q03164 | |
| DGRHSPPMVKNATVH | 211 | Q14558 | |
| NEPPTGMHANLHKAL | 4016 | Q9NYC9 | |
| PGQTLLPRMQEKHLH | 31 | O94887 | |
| GVHPKQAHTMDPQLR | 66 | P49327 | |
| KPMVTHGLSHPVALT | 356 | Q6VVB1 | |
| GDHPAQMQHKPSKRR | 631 | Q6PJW8 | |
| HGLSQAMKLPSPAHH | 1511 | Q5VW36 | |
| PIGHEAPRMLKSHIG | 556 | Q8N4N8 | |
| HMLSGLLNPHQPIAT | 81 | Q5JRS4 | |
| PVKMTPNHGLHLSFR | 1661 | Q8NEY1 | |
| NMAVPKAHRPGDLIH | 1886 | O60469 | |
| HKIPNVMLLAHLTPG | 81 | Q8N9W8 | |
| MKGFPSPRILATHLH | 106 | Q6IMI4 | |
| ELKEMGSQPHSPRVH | 561 | Q8IWB6 | |
| LHPNIKVMRHPDHVS | 441 | Q13393 | |
| KHTARSLHPAMLPAA | 311 | P17542 | |
| RPKQPFMLQHASGEH | 1806 | Q8IZX4 | |
| NGVKPDVMHHISTPL | 101 | Q8N2H9 | |
| PKHSLHLNSSIPCMI | 61 | A0PJY2 | |
| MVTGNHRKPSLLAHP | 116 | Q14943 | |
| MLEGTKNRHPPIVVH | 1106 | Q15678 | |
| CRMPPSHQLDHSKLL | 91 | Q07960 | |
| NVKKVPHHMGHSRNP | 836 | Q93073 | |
| THTLPPMNHLTKLVA | 171 | A6NM43 | |
| HAKLHMREPPGQTTK | 371 | O95785 | |
| LSPQRLCSKHMPQLH | 831 | Q9P2P6 | |
| GTEPIILRNMGPHHS | 186 | Q9C0C4 | |
| GMHPVLQEPKFSSLH | 11 | Q15319 | |
| GPPLLTRHNHLKDFM | 201 | Q13586 | |
| HPQMTFGRLHRIIPK | 96 | Q16384 | |
| KMTIGHREQQRSHPP | 361 | Q8N365 | |
| LHQAASMIHPKEVPP | 666 | Q9H9A5 | |
| SRPLQKGSHPMCKEH | 111 | Q969Q1 | |
| SRPQRSPKRMGVHHL | 526 | Q5JTD0 | |
| HPKMHLAHSTLKPAA | 51 | P01374 | |
| APVVKRPGAMATHHP | 271 | Q9UN79 | |
| MKDSHASKGAPHLPR | 986 | P61129 | |
| QTHKVLGMDLLPPRH | 891 | Q9UPR6 | |
| TPTGHNMKILQPHVI | 2606 | Q96RL7 | |
| FVMRHKGAPHLRPAA | 461 | Q9HAW8 | |
| HASKALIQPGHVPEM | 571 | Q76I76 | |
| RLPNVTGSHMHLPFA | 291 | Q96P16 | |
| MPHRKERPSGSSLHT | 1 | Q96SI1 | |
| HRGHMPPLTSAQQAL | 481 | Q9Y490 | |
| AHKMQLPSAAGLHPT | 196 | Q15050 | |
| KGKILCQSHPQSMPH | 1506 | Q6ZQQ2 | |
| NPPEMRHAILVGNHS | 241 | Q6UWL2 | |
| HMRLHTGEKPFLCPH | 486 | Q9H9D4 | |
| EQAHAMPSPRILKTH | 101 | O75897 | |
| VMRHKGAPHLRPAAH | 466 | P35504 | |
| KHPSMLLIPHFVGST | 361 | Q6P2S7 | |
| GHLSPMRIPHLRGKF | 41 | A8MX80 | |
| KLPHEMSPALHRKIS | 191 | Q96D21 | |
| SRPVNHSVTDHGMKP | 71 | P19634 | |
| HPPEKHGGRTMVQLF | 476 | P08240 | |
| HKGGRMDQQPALPHR | 1291 | Q9HCK4 | |
| RPHTAVLMEKAAQPH | 131 | Q12899 | |
| FVMRHKGAPHLRPAA | 461 | O60656 | |
| PLTALVKHMHRSLGP | 2096 | P78527 | |
| VKHMHRSLGPPQGEE | 2101 | P78527 | |
| VLSPHNSIMFGHLSP | 31 | Q8N9G6 | |
| PQHSLPQGVMHSTKP | 101 | P31629 | |
| LSSGPLHLAQPQIMH | 1146 | P31629 | |
| RLPPIQSMVHAGSFH | 66 | Q6ZQQ6 | |
| PKQPLVLHHPRMTTT | 461 | Q6P2D8 | |
| LHQAGSLMPKAVPRH | 191 | Q9H1B5 | |
| FVMRHKGAPHLRPAA | 461 | Q9HAW7 | |
| PDPIGHNPTHLSNKM | 1571 | Q9UPQ9 | |
| FVMRHKGAPHLRPAA | 461 | Q9HAW9 | |
| VMRHKGAPHLRPAAH | 466 | P22310 | |
| LHKMNHVTPPNVSLG | 146 | P17275 | |
| LMVHVPKPGHKRTDS | 1101 | Q9Y4I1 | |
| LHGTSSQPEHMKQPR | 591 | P29120 |